Thermo Fisher to acquire Mesa Biotech for $450M
January 20, 2021 -- Thermo Fisher Scientific plans to acquire point-of-care molecular diagnostics provider Mesa Biotech for $450 million in cash.
COVID-19 pandemic accelerates adoption of diagnostic testing at point of care
January 11, 2021 -- Out of a very bad year where the COVID-19 pandemic brought the world to its knees has come some good, investors say. Point-of-care diagnostics tests are flourishing, according to panelists at the Biotech Showcase investor conference, held online from January 11-15.  Discuss
Quidel nabs EUA from FDA for SARS-CoV-2 antigen test
December 21, 2020 -- Quidel has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QuickVue point-of-care assay that detects the nucleocapsid protein antigen of the SARS-CoV-2 virus from anterior nares swab specimens.
Beckman Coulter launches high-throughput COVID-19 assay
December 18, 2020 -- Beckman Coulter has debuted a new COVID-19 test, the Access SARS-CoV-2 antigen assay, which the company said is cost-effective and has high throughput.
Inflammatory biomarkers help quickly size up COVID-19 patients
December 17, 2020 -- Rapid blood tests for interferon gamma-induced protein 10 and calprotectin could help in the assessment and triage of COVID-19 patients, according to poster presentations reported by test developers at the annual American Association for Clinical Chemistry meeting.  Discuss
COVID-19 challenges the landscape of rapid testing for infectious diseases
December 17, 2020 -- The future is bright for rapid testing of infectious diseases, but the COVID-19 pandemic has raised a number of challenges that must be addressed, according to speakers at a December 15 session of the American Association for Clinical Chemistry virtual meeting.  Discuss
Researchers develop new COVID-19 diagnosis technology
December 10, 2020 -- South Korean researchers have developed a new technology for point-of-care diagnosis of COVID-19, according to a study published December 3 in Nature Biomedical Engineering.
FDA clears Mesa Biotech's point-of-care strep A test
December 9, 2020 -- The U.S. Food and Drug Administration (FDA) granted 510(k) clearance and a CLIA waiver to Mesa Biotech for its Accula strep A molecular point-of-care test.
Bluejay teams up with Toray on COVID-19 point-of-care test
December 8, 2020 -- Bluejay Diagnostics and Toray Industries are collaborating to develop a point-of-care diagnostic test for assessing disease progression in COVID-19 patients. The test is designed as a triage aid for predicting patients at risk for intubation.
Vaccines won't eliminate the need for COVID-19 testing
November 24, 2020 -- The impending arrival of a vaccine for the SARS-CoV-2 virus is great news for a world weary of fighting the COVID-19 pandemic. But what effect will a vaccine have on lab testing for the novel coronavirus? Bruce Carlson of Kalorama Information explores this question.  Discuss